Bioclinica is a specialty provider of technology-enabled services to contract research organisations (‘CROs’) and pharmaceutical companies, supporting the development of new medical therapies globally.

Bioclinica's solutions enhance the overall efficiency and productivity of clinical trials. The company's core products and services include medical imaging analysis and consultation, cardiovascular safety and efficacy, patient recruitment and retention, central lab services and e-health technologies. The company benefits from increasing demand for outsourcing and the growing adoption of clinical software services, as the number and complexity of clinical trials required to bring new molecules to market grows.

Established in 1990, Bioclinica is headquartered in Pennsylvania, with offices across the US, Europe and Asia. It employs approximately 3,000 people worldwide and serves more than 400 pharmaceutical, biotechnology and medical device clients.